{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-061389","form_type":"8-K","ticker":"WW","cik":"0000105319","company_name":"WW INTERNATIONAL, INC.","filed_at":"2023-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.679118+00:00","generated_at":"2026-06-18T11:04:19.491120+00:00","sec_items":["1.01","2.02","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"WW acquires Sequence for $132M; Q4 revenue $223.9M, operating loss $50.8M","bullets":["Acquires Weekend Health (Sequence) for $132M ($106M net of cash); $65M cash + $35M stock at close, $16M each on 1st and 2nd anniversaries.","Sequence has ~$25M annual revenue run-rate and ~24,000 members; expected close Q2 2023.","Q4 revenue $223.9M (-18.8% YoY); operating loss $50.8M includes $57.6M impairment; adjusted operating income $24.2M.","Full year 2022 revenue $1.04B; operating loss $283.0M includes $396.7M impairment; adjusted operating income $153.5M.","Q1 2023 guidance: revenue ~$235M; operating loss ($30M)-($35M) including ~$20M restructuring charges."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-061389","json":"https://secwatch.observer/filing/0001193125-23-061389.json","markdown":"https://secwatch.observer/filing/0001193125-23-061389.md","text":"https://secwatch.observer/filing/0001193125-23-061389.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105319/000119312523061389/0001193125-23-061389-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105319/000119312523061389/d461379d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T11:04:19.491120+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05e7c9cac87029b12d372f76c650f596ace81cca","claim":"WW INTERNATIONAL, INC. reported financial results for fourth quarter and full year fiscal 2022.","evidence_excerpt":"On March 6, 2023, the Company issued a press release announcing its financial results for its fiscal quarter and fiscal year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/105319/000119312523061389/0001193125-23-061389-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full year fiscal 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"2f9c1a9482798e53cfdc5ff409bf97976764ac5e","claim":"WW INTERNATIONAL, INC. entered into Merger Agreement with Weekend Health, Inc. valued at $132.0 million (effective 2023-03-04).","evidence_excerpt":"On March 4, 2023, WW International, Inc. (the “Company”), Well Holdings, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), Weekend Health, Inc., a Delaware corporation (“Weekend Health”), and Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as the Equityholders’ Representative for Weekend Health, entered into an Agreement and Plan of Merger (the “Merger Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/105319/000119312523061389/0001193125-23-061389-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Weekend Health, Inc."},{"label":"Value","value":"$132.0 million"},{"label":"Effective","value":"2023-03-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}